Structure

Physi-Chem Properties

Molecular Weight:  418.2
Volume:  420.488
LogP:  2.775
LogD:  2.368
LogS:  -4.304
# Rotatable Bonds:  4
TPSA:  103.04
# H-Bond Aceptor:  7
# H-Bond Donor:  1
# Rings:  4
# Heavy Atoms:  7

MedChem Properties

QED Drug-Likeness Score:  0.736
Synthetic Accessibility Score:  4.778
Fsp3:  0.696
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.843
MDCK Permeability:  3.980445762863383e-05
Pgp-inhibitor:  0.99
Pgp-substrate:  0.002
Human Intestinal Absorption (HIA):  0.004
20% Bioavailability (F20%):  0.013
30% Bioavailability (F30%):  0.128

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.315
Plasma Protein Binding (PPB):  82.35176086425781%
Volume Distribution (VD):  1.222
Pgp-substrate:  22.189863204956055%

ADMET: Metabolism

CYP1A2-inhibitor:  0.26
CYP1A2-substrate:  0.072
CYP2C19-inhibitor:  0.379
CYP2C19-substrate:  0.241
CYP2C9-inhibitor:  0.637
CYP2C9-substrate:  0.081
CYP2D6-inhibitor:  0.026
CYP2D6-substrate:  0.142
CYP3A4-inhibitor:  0.514
CYP3A4-substrate:  0.476

ADMET: Excretion

Clearance (CL):  3.731
Half-life (T1/2):  0.139

ADMET: Toxicity

hERG Blockers:  0.864
Human Hepatotoxicity (H-HT):  0.631
Drug-inuced Liver Injury (DILI):  0.795
AMES Toxicity:  0.043
Rat Oral Acute Toxicity:  0.838
Maximum Recommended Daily Dose:  0.924
Skin Sensitization:  0.243
Carcinogencity:  0.767
Eye Corrosion:  0.004
Eye Irritation:  0.012
Respiratory Toxicity:  0.973

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC81405

Natural Product ID:  NPC81405
Common Name*:   Norcaesalpinin B
IUPAC Name:   [(1S,3R,4aR,6aR,11aS,11bS)-1-acetyloxy-4a-hydroxy-4,4,11b-trimethyl-7-oxo-1,2,3,5,6,6a,11,11a-octahydronaphtho[2,1-f][1]benzofuran-3-yl] acetate
Synonyms:  
Standard InCHIKey:  MPFACQITBMQUJJ-PQIIFOIOSA-N
Standard InCHI:  InChI=1S/C23H30O7/c1-12(24)29-18-11-19(30-13(2)25)22(5)16-10-17-15(7-9-28-17)20(26)14(16)6-8-23(22,27)21(18,3)4/h7,9,14,16,18-19,27H,6,8,10-11H2,1-5H3/t14-,16+,18-,19+,22+,23-/m1/s1
SMILES:  CC(=O)O[C@@H]1C[C@@H]([C@]2(C)[C@H]3Cc4c(cco4)C(=O)[C@@H]3CC[C@]2(C1(C)C)O)OC(=O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL464366
PubChem CID:   10895033
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0001634] Naphthofurans

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO1064 Caesalpinia bonducella Species Fabaceae Eukaryota n.a. seed n.a. DOI[10.1016/S0040-4039(01)89961-5]
NPO26402 Caesalpinia crista Species Fabaceae Eukaryota n.a. Indonesia n.a. PMID[15921414]
NPO26402 Caesalpinia crista Species Fabaceae Eukaryota n.a. seed kernel n.a. PMID[15921414]
NPO26402 Caesalpinia crista Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO1064 Caesalpinia bonducella Species Fabaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO26402 Caesalpinia crista Species Fabaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 260.0 nM PMID[538563]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC81405 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9933 High Similarity NPC140952
0.9673 High Similarity NPC56358
0.9548 High Similarity NPC270312
0.9416 High Similarity NPC18986
0.9408 High Similarity NPC104736
0.9408 High Similarity NPC41880
0.9359 High Similarity NPC121995
0.9351 High Similarity NPC287559
0.9346 High Similarity NPC304692
0.9333 High Similarity NPC212257
0.9324 High Similarity NPC233763
0.9295 High Similarity NPC472664
0.9167 High Similarity NPC188649
0.9167 High Similarity NPC68848
0.9161 High Similarity NPC474611
0.9139 High Similarity NPC211625
0.9108 High Similarity NPC285567
0.9108 High Similarity NPC283209
0.9108 High Similarity NPC88841
0.9108 High Similarity NPC288602
0.9018 High Similarity NPC472665
0.8974 High Similarity NPC88007
0.8974 High Similarity NPC195954
0.8974 High Similarity NPC194499
0.8968 High Similarity NPC75310
0.8954 High Similarity NPC228842
0.894 High Similarity NPC62799
0.8926 High Similarity NPC263337
0.8903 High Similarity NPC114880
0.8882 High Similarity NPC296558
0.8861 High Similarity NPC8389
0.8854 High Similarity NPC472772
0.8839 High Similarity NPC475777
0.8839 High Similarity NPC121615
0.8839 High Similarity NPC294511
0.8824 High Similarity NPC19747
0.8805 High Similarity NPC79571
0.8797 High Similarity NPC123153
0.8782 High Similarity NPC178932
0.8773 High Similarity NPC294512
0.8758 High Similarity NPC224418
0.8758 High Similarity NPC71821
0.8734 High Similarity NPC7059
0.8726 High Similarity NPC179170
0.8726 High Similarity NPC469336
0.8725 High Similarity NPC202260
0.8718 High Similarity NPC75906
0.871 High Similarity NPC196864
0.871 High Similarity NPC477404
0.8696 High Similarity NPC276735
0.8688 High Similarity NPC472771
0.8667 High Similarity NPC148374
0.8662 High Similarity NPC282445
0.8654 High Similarity NPC144010
0.8642 High Similarity NPC86800
0.8642 High Similarity NPC475779
0.8642 High Similarity NPC277618
0.8634 High Similarity NPC663
0.8634 High Similarity NPC224394
0.8634 High Similarity NPC472773
0.8625 High Similarity NPC472299
0.8618 High Similarity NPC243577
0.8616 High Similarity NPC249021
0.8614 High Similarity NPC176413
0.8614 High Similarity NPC56953
0.8608 High Similarity NPC264943
0.8608 High Similarity NPC472786
0.8608 High Similarity NPC88958
0.8599 High Similarity NPC246164
0.8599 High Similarity NPC469503
0.8599 High Similarity NPC145830
0.8591 High Similarity NPC307401
0.859 High Similarity NPC159927
0.859 High Similarity NPC469335
0.8589 High Similarity NPC473766
0.8589 High Similarity NPC473753
0.8571 High Similarity NPC263432
0.8571 High Similarity NPC329938
0.8562 High Similarity NPC251865
0.8562 High Similarity NPC84479
0.8562 High Similarity NPC473368
0.8553 High Similarity NPC121158
0.8545 High Similarity NPC475237
0.8545 High Similarity NPC475641
0.8544 High Similarity NPC30222
0.8537 High Similarity NPC160651
0.8535 High Similarity NPC272590
0.8528 High Similarity NPC308156
0.8526 High Similarity NPC472654
0.8526 High Similarity NPC195325
0.8523 High Similarity NPC46896
0.8519 High Similarity NPC477405
0.8519 High Similarity NPC469338
0.8519 High Similarity NPC419
0.8519 High Similarity NPC292389
0.8516 High Similarity NPC255414
0.8516 High Similarity NPC216755
0.8516 High Similarity NPC286038
0.8509 High Similarity NPC25255
0.8503 High Similarity NPC167340
0.85 High Similarity NPC167142
0.85 High Similarity NPC221992
0.85 High Similarity NPC299038
0.8497 Intermediate Similarity NPC205071
0.8497 Intermediate Similarity NPC103134
0.8497 Intermediate Similarity NPC64568
0.8497 Intermediate Similarity NPC267632
0.8491 Intermediate Similarity NPC35000
0.8491 Intermediate Similarity NPC469850
0.8491 Intermediate Similarity NPC25351
0.8485 Intermediate Similarity NPC44602
0.8476 Intermediate Similarity NPC472784
0.8476 Intermediate Similarity NPC136641
0.8476 Intermediate Similarity NPC472282
0.8476 Intermediate Similarity NPC472774
0.8476 Intermediate Similarity NPC173516
0.8476 Intermediate Similarity NPC472775
0.8471 Intermediate Similarity NPC476122
0.8467 Intermediate Similarity NPC42400
0.8466 Intermediate Similarity NPC469849
0.8466 Intermediate Similarity NPC476856
0.8466 Intermediate Similarity NPC276551
0.8466 Intermediate Similarity NPC470940
0.8466 Intermediate Similarity NPC476857
0.8466 Intermediate Similarity NPC476858
0.8466 Intermediate Similarity NPC476860
0.8462 Intermediate Similarity NPC66991
0.8457 Intermediate Similarity NPC193798
0.8457 Intermediate Similarity NPC470939
0.8457 Intermediate Similarity NPC82851
0.8457 Intermediate Similarity NPC69028
0.8452 Intermediate Similarity NPC97904
0.8447 Intermediate Similarity NPC475967
0.8447 Intermediate Similarity NPC299094
0.8447 Intermediate Similarity NPC10051
0.8447 Intermediate Similarity NPC477403
0.8442 Intermediate Similarity NPC476944
0.8431 Intermediate Similarity NPC52412
0.8428 Intermediate Similarity NPC57998
0.8428 Intermediate Similarity NPC10429
0.8424 Intermediate Similarity NPC471397
0.8424 Intermediate Similarity NPC255787
0.8424 Intermediate Similarity NPC291742
0.8424 Intermediate Similarity NPC125465
0.8421 Intermediate Similarity NPC18904
0.8415 Intermediate Similarity NPC470875
0.8415 Intermediate Similarity NPC23387
0.8415 Intermediate Similarity NPC100849
0.8408 Intermediate Similarity NPC125182
0.8408 Intermediate Similarity NPC69647
0.8405 Intermediate Similarity NPC39986
0.8405 Intermediate Similarity NPC475039
0.8405 Intermediate Similarity NPC476197
0.8405 Intermediate Similarity NPC476035
0.8405 Intermediate Similarity NPC14499
0.8405 Intermediate Similarity NPC302369
0.8405 Intermediate Similarity NPC134254
0.8402 Intermediate Similarity NPC295914
0.8402 Intermediate Similarity NPC472661
0.8397 Intermediate Similarity NPC281398
0.8397 Intermediate Similarity NPC471174
0.8397 Intermediate Similarity NPC221809
0.8395 Intermediate Similarity NPC477402
0.8395 Intermediate Similarity NPC335761
0.8395 Intermediate Similarity NPC333139
0.8387 Intermediate Similarity NPC41182
0.8385 Intermediate Similarity NPC261597
0.8375 Intermediate Similarity NPC44675
0.8375 Intermediate Similarity NPC92979
0.8375 Intermediate Similarity NPC214541
0.8373 Intermediate Similarity NPC472660
0.8373 Intermediate Similarity NPC302392
0.8365 Intermediate Similarity NPC476201
0.8365 Intermediate Similarity NPC268905
0.8364 Intermediate Similarity NPC476850
0.8364 Intermediate Similarity NPC476861
0.8364 Intermediate Similarity NPC476853
0.8354 Intermediate Similarity NPC123088
0.8354 Intermediate Similarity NPC156189
0.8354 Intermediate Similarity NPC472298
0.8344 Intermediate Similarity NPC472767
0.8344 Intermediate Similarity NPC197596
0.8344 Intermediate Similarity NPC5079
0.8344 Intermediate Similarity NPC200782
0.8333 Intermediate Similarity NPC158525
0.8333 Intermediate Similarity NPC346
0.8333 Intermediate Similarity NPC262198
0.8333 Intermediate Similarity NPC472823
0.8323 Intermediate Similarity NPC238843
0.8323 Intermediate Similarity NPC107646
0.8323 Intermediate Similarity NPC474542
0.8323 Intermediate Similarity NPC263265
0.8323 Intermediate Similarity NPC60973
0.8323 Intermediate Similarity NPC142113
0.8323 Intermediate Similarity NPC199044
0.8323 Intermediate Similarity NPC469485
0.8322 Intermediate Similarity NPC293253
0.8313 Intermediate Similarity NPC44606
0.8301 Intermediate Similarity NPC67003
0.8293 Intermediate Similarity NPC234660

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC81405 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8471 Intermediate Similarity NPD8434 Phase 2
0.8395 Intermediate Similarity NPD5537 Clinical (unspecified phase)
0.8261 Intermediate Similarity NPD5760 Phase 2
0.8261 Intermediate Similarity NPD5761 Phase 2
0.8012 Intermediate Similarity NPD3226 Approved
0.8 Intermediate Similarity NPD1471 Phase 3
0.7927 Intermediate Similarity NPD7819 Suspended
0.7914 Intermediate Similarity NPD7411 Suspended
0.7898 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7892 Intermediate Similarity NPD3749 Approved
0.7888 Intermediate Similarity NPD920 Approved
0.7861 Intermediate Similarity NPD6764 Approved
0.7861 Intermediate Similarity NPD6765 Approved
0.7771 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7771 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7744 Intermediate Similarity NPD6599 Discontinued
0.7736 Intermediate Similarity NPD4628 Phase 3
0.7733 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7711 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7684 Intermediate Similarity NPD6785 Approved
0.7684 Intermediate Similarity NPD6784 Approved
0.7658 Intermediate Similarity NPD2344 Approved
0.7654 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7643 Intermediate Similarity NPD2799 Discontinued
0.764 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7616 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7607 Intermediate Similarity NPD6273 Approved
0.7595 Intermediate Similarity NPD2796 Approved
0.7574 Intermediate Similarity NPD7075 Discontinued
0.7562 Intermediate Similarity NPD2800 Approved
0.7557 Intermediate Similarity NPD6559 Discontinued
0.7547 Intermediate Similarity NPD2346 Discontinued
0.7546 Intermediate Similarity NPD2534 Approved
0.7546 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7546 Intermediate Similarity NPD2532 Approved
0.7546 Intermediate Similarity NPD2533 Approved
0.7545 Intermediate Similarity NPD6801 Discontinued
0.75 Intermediate Similarity NPD1549 Phase 2
0.75 Intermediate Similarity NPD6808 Phase 2
0.7485 Intermediate Similarity NPD6799 Approved
0.7485 Intermediate Similarity NPD5494 Approved
0.7484 Intermediate Similarity NPD1551 Phase 2
0.7471 Intermediate Similarity NPD7473 Discontinued
0.7469 Intermediate Similarity NPD2309 Approved
0.7453 Intermediate Similarity NPD1243 Approved
0.7442 Intermediate Similarity NPD6959 Discontinued
0.7439 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7439 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7438 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7438 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7427 Intermediate Similarity NPD919 Approved
0.7412 Intermediate Similarity NPD7768 Phase 2
0.7407 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7399 Intermediate Similarity NPD6232 Discontinued
0.7396 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7391 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7372 Intermediate Similarity NPD2313 Discontinued
0.7341 Intermediate Similarity NPD1247 Approved
0.7312 Intermediate Similarity NPD1510 Phase 2
0.7312 Intermediate Similarity NPD7033 Discontinued
0.731 Intermediate Similarity NPD3882 Suspended
0.7301 Intermediate Similarity NPD3750 Approved
0.7288 Intermediate Similarity NPD5844 Phase 1
0.7283 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7267 Intermediate Similarity NPD6100 Approved
0.7267 Intermediate Similarity NPD6099 Approved
0.7262 Intermediate Similarity NPD7458 Discontinued
0.7262 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7261 Intermediate Similarity NPD3764 Approved
0.7261 Intermediate Similarity NPD3268 Approved
0.7259 Intermediate Similarity NPD8404 Phase 2
0.7257 Intermediate Similarity NPD3926 Phase 2
0.7251 Intermediate Similarity NPD3817 Phase 2
0.7235 Intermediate Similarity NPD1934 Approved
0.7232 Intermediate Similarity NPD3818 Discontinued
0.7219 Intermediate Similarity NPD4380 Phase 2
0.7212 Intermediate Similarity NPD7236 Approved
0.7209 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7205 Intermediate Similarity NPD3748 Approved
0.7198 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7195 Intermediate Similarity NPD7003 Approved
0.7195 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.719 Intermediate Similarity NPD1608 Approved
0.7188 Intermediate Similarity NPD1607 Approved
0.7182 Intermediate Similarity NPD8313 Approved
0.7182 Intermediate Similarity NPD8312 Approved
0.717 Intermediate Similarity NPD1240 Approved
0.7168 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.716 Intermediate Similarity NPD2935 Discontinued
0.7152 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7151 Intermediate Similarity NPD5402 Approved
0.7143 Intermediate Similarity NPD8127 Discontinued
0.7143 Intermediate Similarity NPD5403 Approved
0.7134 Intermediate Similarity NPD6832 Phase 2
0.7126 Intermediate Similarity NPD5401 Approved
0.7115 Intermediate Similarity NPD2798 Approved
0.7111 Intermediate Similarity NPD5953 Discontinued
0.7107 Intermediate Similarity NPD8032 Phase 2
0.7102 Intermediate Similarity NPD7229 Phase 3
0.7093 Intermediate Similarity NPD2801 Approved
0.7081 Intermediate Similarity NPD6651 Approved
0.7078 Intermediate Similarity NPD3972 Approved
0.7063 Intermediate Similarity NPD4140 Approved
0.7051 Intermediate Similarity NPD3267 Approved
0.7051 Intermediate Similarity NPD3266 Approved
0.7044 Intermediate Similarity NPD1699 Clinical (unspecified phase)
0.7041 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7035 Intermediate Similarity NPD6279 Approved
0.7035 Intermediate Similarity NPD37 Approved
0.7035 Intermediate Similarity NPD6280 Approved
0.7022 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7022 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7022 Intermediate Similarity NPD6166 Phase 2
0.7013 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7011 Intermediate Similarity NPD4965 Approved
0.7011 Intermediate Similarity NPD4967 Phase 2
0.7011 Intermediate Similarity NPD4966 Approved
0.7006 Intermediate Similarity NPD5711 Approved
0.7006 Intermediate Similarity NPD5710 Approved
0.7 Intermediate Similarity NPD7239 Suspended
0.7 Intermediate Similarity NPD7286 Phase 2
0.6994 Remote Similarity NPD4308 Phase 3
0.6994 Remote Similarity NPD1509 Clinical (unspecified phase)
0.6993 Remote Similarity NPD17 Approved
0.6989 Remote Similarity NPD4287 Approved
0.6968 Remote Similarity NPD9717 Approved
0.6964 Remote Similarity NPD1511 Approved
0.6964 Remote Similarity NPD6143 Clinical (unspecified phase)
0.6954 Remote Similarity NPD5616 Clinical (unspecified phase)
0.6954 Remote Similarity NPD2296 Approved
0.6949 Remote Similarity NPD7199 Phase 2
0.6944 Remote Similarity NPD7799 Discontinued
0.6944 Remote Similarity NPD3751 Discontinued
0.6944 Remote Similarity NPD7177 Discontinued
0.6943 Remote Similarity NPD1203 Approved
0.6943 Remote Similarity NPD2797 Approved
0.6943 Remote Similarity NPD1470 Approved
0.694 Remote Similarity NPD4419 Clinical (unspecified phase)
0.6932 Remote Similarity NPD6234 Discontinued
0.6914 Remote Similarity NPD1899 Clinical (unspecified phase)
0.6914 Remote Similarity NPD6355 Discontinued
0.6909 Remote Similarity NPD6003 Clinical (unspecified phase)
0.6909 Remote Similarity NPD6006 Clinical (unspecified phase)
0.6909 Remote Similarity NPD6004 Phase 3
0.6909 Remote Similarity NPD6005 Phase 3
0.6909 Remote Similarity NPD6002 Phase 3
0.6907 Remote Similarity NPD7435 Discontinued
0.6906 Remote Similarity NPD7804 Clinical (unspecified phase)
0.6898 Remote Similarity NPD8397 Clinical (unspecified phase)
0.6886 Remote Similarity NPD4110 Phase 3
0.6886 Remote Similarity NPD4109 Clinical (unspecified phase)
0.6883 Remote Similarity NPD3412 Clinical (unspecified phase)
0.6883 Remote Similarity NPD1778 Approved
0.6882 Remote Similarity NPD1512 Approved
0.6882 Remote Similarity NPD8150 Discontinued
0.6879 Remote Similarity NPD1876 Approved
0.6875 Remote Similarity NPD5952 Clinical (unspecified phase)
0.6875 Remote Similarity NPD8285 Discontinued
0.6872 Remote Similarity NPD7184 Clinical (unspecified phase)
0.6868 Remote Similarity NPD7074 Phase 3
0.6852 Remote Similarity NPD4307 Phase 2
0.6848 Remote Similarity NPD4338 Clinical (unspecified phase)
0.6839 Remote Similarity NPD6781 Approved
0.6839 Remote Similarity NPD6780 Approved
0.6839 Remote Similarity NPD6778 Approved
0.6839 Remote Similarity NPD6782 Approved
0.6839 Remote Similarity NPD6776 Approved
0.6839 Remote Similarity NPD6779 Approved
0.6839 Remote Similarity NPD6777 Approved
0.6833 Remote Similarity NPD2403 Approved
0.6832 Remote Similarity NPD411 Approved
0.6832 Remote Similarity NPD6798 Discontinued
0.6831 Remote Similarity NPD7993 Clinical (unspecified phase)
0.6829 Remote Similarity NPD7097 Phase 1
0.6816 Remote Similarity NPD3787 Discontinued
0.6813 Remote Similarity NPD7054 Approved
0.681 Remote Similarity NPD447 Suspended
0.68 Remote Similarity NPD1465 Phase 2
0.6786 Remote Similarity NPD8166 Discontinued
0.6782 Remote Similarity NPD5889 Approved
0.6782 Remote Similarity NPD5890 Approved
0.6776 Remote Similarity NPD7472 Approved
0.6774 Remote Similarity NPD8407 Phase 2
0.6772 Remote Similarity NPD1283 Approved
0.677 Remote Similarity NPD7095 Approved
0.6753 Remote Similarity NPD9545 Approved
0.6747 Remote Similarity NPD5405 Approved
0.6747 Remote Similarity NPD5408 Approved
0.6747 Remote Similarity NPD5404 Approved
0.6747 Remote Similarity NPD5406 Approved
0.6746 Remote Similarity NPD3887 Approved
0.6739 Remote Similarity NPD6797 Phase 2
0.6735 Remote Similarity NPD7698 Approved
0.6735 Remote Similarity NPD7697 Approved
0.6735 Remote Similarity NPD7696 Phase 3
0.6735 Remote Similarity NPD7497 Discontinued
0.6724 Remote Similarity NPD6585 Discontinued
0.6723 Remote Similarity NPD7057 Phase 3
0.6723 Remote Similarity NPD7058 Phase 2
0.6707 Remote Similarity NPD1933 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data